AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 237 filers reported holding AMICUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,787,726 | +162.0% | 393,728 | +170.6% | 0.00% | +100.0% |
| Q2 2023 | $1,827,580 | +13.4% | 145,508 | +0.2% | 0.00% | 0.0% |
| Q1 2023 | $1,610,922 | -8.4% | 145,259 | +0.8% | 0.00% | 0.0% |
| Q4 2022 | $1,759,180 | +50.7% | 144,077 | +28.8% | 0.00% | 0.0% |
| Q3 2022 | $1,167,000 | -8.9% | 111,821 | -6.3% | 0.00% | 0.0% |
| Q2 2022 | $1,281,000 | +30.3% | 119,304 | +14.9% | 0.00% | – |
| Q1 2022 | $983,000 | -25.8% | 103,798 | -9.6% | 0.00% | -100.0% |
| Q4 2021 | $1,325,000 | +64.4% | 114,759 | +36.0% | 0.00% | – |
| Q3 2021 | $806,000 | +16.0% | 84,378 | +17.1% | 0.00% | – |
| Q2 2021 | $695,000 | -24.2% | 72,086 | -22.3% | 0.00% | -100.0% |
| Q1 2021 | $917,000 | +16.8% | 92,768 | +172.9% | 0.00% | 0.0% |
| Q4 2020 | $785,000 | +74.4% | 33,992 | +6.6% | 0.00% | – |
| Q3 2020 | $450,000 | +1263.6% | 31,873 | +1396.4% | 0.00% | – |
| Q2 2018 | $33,000 | +6.5% | 2,130 | +2.7% | 0.00% | – |
| Q1 2018 | $31,000 | 0.0% | 2,073 | -4.7% | 0.00% | – |
| Q4 2017 | $31,000 | +6.9% | 2,176 | +12.2% | 0.00% | – |
| Q3 2017 | $29,000 | – | 1,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |